Cross-sectional study: long term follow-up care for pediatric cancer survivors in a developing country, Turkey: current status, challenges, and future perspectives


Journal

Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 29 11 2019
accepted: 04 07 2020
entrez: 7 7 2020
pubmed: 7 7 2020
medline: 12 10 2021
Statut: epublish

Résumé

The main purpose of this study is to determine the current status of long-term follow-up (LTFU) for childhood cancer survivors and the challenges of LTFU for pediatric cancer survivors at pediatric oncology institutions in Turkey. A questionnaire was e-mailed to the directors of 33 pediatric oncology centers (POCs) registered in the Turkish Pediatric Oncology Group (TPOG). Of these 33 active TPOG institutions, 21 participated in the study and returned their completed questionnaires. Only 1 of the 21 participating centers had a separate LTFU clinic. The remaining centers provided LTFU care for childhood cancer survivors at the pediatric oncology outpatient clinic. Of these centers, 17 (80.9%) reported difficulty in transition from the pediatric clinic to the adult clinic, 14 (66.6%) reported insufficient care providers, and 12 (57.1%) reported insufficient time and transportation problems. As neglected late effects, 16 (76.1%) centers reported psychosocial and getty job problems and 11 (52.3%) reported sexual and cognitive problems. None of the centers had their own LTFU guidelines for their daily LTFU practice This study was the first to gain an overview of the needs of POCs and the gaps in survivorship services in Turkey. The results from this study will help to develop a national health care system and national guidelines for pediatric cancer survivors.

Identifiants

pubmed: 32628434
doi: 10.3906/sag-1911-193
pmc: PMC7775715
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1916-1921

Informations de copyright

This work is licensed under a Creative Commons Attribution 4.0 International License.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest or funding to disclose.

Références

Health Policy. 2015 Sep;119(9):1153-63
pubmed: 26183890
Pediatr Blood Cancer. 2017 Feb;64(2):346-352
pubmed: 27463688
N Engl J Med. 2006 Oct 12;355(15):1572-82
pubmed: 17035650
Lancet. 2013 Jul 6;382(9886):65-99
pubmed: 23810020
Health Policy Plan. 2017 Feb;32(1):57-67
pubmed: 27515404
Pediatr Blood Cancer. 2009 Dec 15;53(7):1295-301
pubmed: 19688835
Pediatr Hematol Oncol. 2012 Feb;29(1):38-49
pubmed: 22304009
Jpn J Clin Oncol. 2016 Jul;46(7):599-604
pubmed: 27162321
J Clin Oncol. 2014 Apr 20;32(12):1218-27
pubmed: 24638000
Asia Pac J Oncol Nurs. 2015 Jul-Sep;2(3):136-143
pubmed: 27981107
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
pubmed: 24488779
Asia Pac J Clin Oncol. 2017 Dec;13(6):407-415
pubmed: 28670761
Curr Pediatr Rev. 2017;13(1):34-41
pubmed: 27848891
N Engl J Med. 2018 Dec 20;379(25):2438-2450
pubmed: 30575480
Pediatr Blood Cancer. 2009 Jan;52(1):113-5
pubmed: 18821577
BMC Cancer. 2017 Nov 6;17(1):715
pubmed: 29110686
Turk J Haematol. 2016 Mar 5;33(1):66-70
pubmed: 26377258
J Clin Oncol. 2010 Nov 10;28(32):4810-8
pubmed: 20351333
Pediatr Blood Cancer. 2011 Dec 15;57(7):1186-90
pubmed: 21674761

Auteurs

Sonay İncesoy Özdemİr (S)

Department of Pediatric Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey

Nurdan Taçyıldız (N)

Department of Pediatric Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey

Alİ Varan (A)

Department of Pediatric Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

Rejİn Kebudi (R)

Institute of Oncology, İstanbul University, İstanbul, Turkey

Osman Bülent Zülfikar (OB)

Institute of Oncology, İstanbul University, İstanbul, Turkey

Tülin Tiraje Celkan (TT)

Department of Pediatric Hematology Oncology, Faculty of Medicine, İstanbul University, İstanbul, Turke

Gürses Şahin (G)

Department of Pediatric Oncology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey

Funda Vesile Çorapcıoğlu (FV)

Department of Pediatric Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey

Zuhal Keskin Yıldırım (Z)

Department of Pediatric Oncology, Faculty of Medicine, Atatürk University, Erzurum, Turkey

Faruk Güçlü Pınarlı (FG)

Department of Pediatric Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey
Department of Pediatric Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey

Hatice Nur Olgun (HN)

Department of Pediatric Oncology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey

Neriman Sarı (N)

Department of Pediatric Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey

Ayhan Dağdemir (A)

Department of Pediatric Oncology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey

Derya Özyörük (D)

Department of Pediatric Oncology, Ankara Children’s Hematology and Oncology Training and Research Hospital, Ankara, Turkey

Tuba Eren (T)

Department of Pediatric Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey

Fatma Betül Çakır (FB)

Department of Pediatric Hematology Oncology, Faculty of Medicine, Bezmiâlem Vakıf University, İstanbul, Turkey

Başak Adaklı Aksoy (B)

Department of Pediatric Hematology Oncology, Faculty of Medicine, Medeniyet University, İstanbul, Turkey

Ceyhun Bozkurt (C)

Department of Pediatric Hematology Oncology, Faculty of Medicine, Istinye University, Bahçelievler Medikal Park Hospital, İstanbul, Turkey

Elif Güler (E)

Department of Pediatric Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey

Ali Aykan Özgüven (AA)

Department of Pediatric Oncology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey

Mehmet Fatih Erbey (MF)

Department of Pediatric Hematology Oncology, Faculty of Medicine, Koç University, Ankara, Turkey

Melda Berber Hamamci (M)

Department of Pediatric Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey

Handan Dinçaslan (H)

Department of Pediatric Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey

Emel Ünal (E)

Department of Pediatric Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey

Mehmet Kantar (M)

Department of Pediatric Oncology, Faculty of Medicine, Ege University, İzmir, Turkey

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH